Incorporation of paclitaxel solid dispersions with poloxamer188 or polyethylene glycol to tune drug release from poly(ϵ-caprolactone) films

References

• Lei L, Guo SR, Chen WL, Rong HJ, Lu F. (2011). Stents as a platform for drug delivery. Expert OpIn Drug Deliv, 8:813–831.
   PubMed Web of Science ®Google Scholar
• Sousa JE, Costa MA, Abizaid A, Sousa AG, Feres F, Mattos LA et al. (2003). Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation, 107:24–27.
   PubMed Web of Science ®Google Scholar
• Bennett MR. (2003). In-stent stenosis: pathology and implications for the development of drug eluting stents. Heart, 89:218–224.
   PubMed Web of Science ®Google Scholar
• Stone GW, Ellis SG, O’Shaughnessy CD, Martin SL, Satler L, McGarry T et al.; TAXUS V ISR Investigators. (2006). Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis withIn bare-metal stents: the TAXUS V ISR randomized trial. JAMA, 295:1253–1263.
   PubMed Web of Science ®Google Scholar
• Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S et al.; TAXUS II Study Group. (2003). Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation, 108:788–794.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. (2004). Poly-epsilon-caprolactone microspheres and nanospheres: an overview. Int J Pharm, 278:1–23.
   PubMed Web of Science ®Google Scholar
• Vandamme TF, Legras R. (1995). Physico-mechanical properties of poly (epsilon-caprolactone) for the construction of rumino-reticulum devices for grazing animals. Biomaterials, 16:1395–1400.
   PubMed Web of Science ®Google Scholar
• Lei L, Liu X, Guo S, Tang M, Cheng L, Tian L. (2010). 5-Fluorouracil-loaded multilayered films for drug controlled releasing stent application: Drug release, microstructure, and ex vivo permeation behaviors. J Control Release, 146:45–53.
   PubMed Web of Science ®Google Scholar
• Hiatt BL, Ikeno F, Yeung AC, Carter AJ. (2002). Drug-eluting stents for the prevention of restenosis: In quest for the Holy Grail. Catheter Cardiovasc Interv, 55:409–417.
   PubMed Web of Science ®Google Scholar
• Tsuji T, Tamai H, Igaki K, Kyo E, Kosuga K, Hata T, et al. (2003). Biodegradable stents as a platform to drug loading. Acute Cardiac Care, 5:13–16.
   Google Scholar
• Anis RR, Karsch KR. (2006). The future of drug eluting stents. Heart, 92:585–588.
   PubMed Web of Science ®Google Scholar
• Lao LL, Venkatraman SS. (2008). Paclitaxel release from single and double-layered poly(DL-lactide-co-glycolide)/poly(L-lactide) film for biodegradable coronary stent application. J Biomed Mater Res A, 87:1–7.
   PubMed Web of Science ®Google Scholar
• Zilberman M, Eberhart RC. (2006). Drug-eluting bioresorbable stents for various applications. Annu Rev Biomed Eng, 8:153–180.
   PubMed Web of Science ®Google Scholar
• Uurto I, Kotsar A, Isotalo T, Mikkonen J, Martikainen PM, Kellomäki M et al. (2007). Tissue biocompatibility of new biodegradable drug-eluting stent materials. J Mater Sci Mater Med, 18:1543–1547.
   PubMed Web of Science ®Google Scholar
• Song CX, Labhasetwar V, Levy RJ. (1997). Controlled release of U-86983 from double-layer biodegradable matrices: effect of additives on release mechanism and kinetics. J Control Release, 45:177–192.
   Web of Science ®Google Scholar
• Dordunoo SK, Oktaba AMC, Hunter W, Min W, Cruz T, Burt HM. (1997). Release of taxol from poly(ϵ-caprolactone) pastes: effect of water-soluble additives. J Control Release, 44:87–94.
   Web of Science ®Google Scholar
• Tang M, Hou J, Lei L, Liu X, Guo S, Wang Z et al. (2010). Preparation, characterization and properties of partially hydrolyzed ethylene vinyl acetate copolymer films for controlled drug release. Int J Pharm, 400:66–73.
   PubMed Web of Science ®Google Scholar
• Duncan QMC. (2002). The mechanisms of drug release from solid dispersions In water-soluble polymers. Int J Pharm, 231:131–144.
   PubMed Web of Science ®Google Scholar
• Leuner C, Dressman J. (2000). Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm, 50:47–60.
   PubMed Web of Science ®Google Scholar
• Newa M, Bhandari KH, Li DX, Kwon TH, Kim JA, Yoo BK et al. (2007). Preparation, characterization and In vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188. Int J Pharm, 343:228–237.
   PubMed Web of Science ®Google Scholar
• Vasconcelos T, Sarmento B, Costa P. (2007). Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today, 12:1068–1075.
   PubMed Web of Science ®Google Scholar
• Guyot M, Fawaz F, Bildet J, Bonini F, Lagueny AM. (1995). Physicochemical characterization and dissolution of norfloxacin/cyclodextrIn inclusion compounds and PEG solid dispersions. Int J Pharm, 123:53–63.
   Web of Science ®Google Scholar
• Zerrouk N, Chemtob C, Arnaud P, Toscani S, Dugue J. (2001). In vitro and In vivo evaluation of carbamazepine-PEG 6000 solid dispersions. Int J Pharm, 225:49–62.
   PubMed Web of Science ®Google Scholar
• Vijaya Kumar SG, Mishra DN. (2006). Preparation, characterization and In vitro dissolution studies of solid dispersion of meloxicam with PEG 6000. Yakugaku Zasshi, 126:657–664.
   PubMed Web of Science ®Google Scholar
• Ali W, Williams AC, Rawlinson CF. (2010). Stochiometrically governed molecular interactions In drug: poloxamer solid dispersions. Int J Pharm, 391:162–168.
   PubMed Web of Science ®Google Scholar
• Chutimaworapan S, Ritthidej GC, Yonemochi E, Oguchi T, Yamamoto K. (2000). Effect of water-soluble carriers on dissolution characteristics of nifedipine solid dispersions. Drug Dev Ind Pharm, 26:1141–1150.
   PubMed Web of Science ®Google Scholar
• Palanisamy M, Khanam J. (2011). Solid dispersion of prednisolone: solid state characterization and improvement of dissolution profile. Drug Dev Ind Pharm, 37:373–386.
   PubMed Web of Science ®Google Scholar
• Liu X, Lei L, Hou JW, Tang MF, Guo SR, Wang ZM et al. (2011). Evaluation of two polymeric blends (EVA/PLA and EVA/PEG) as coating film materials for paclitaxel-eluting stent application. J Mater Sci Mater Med, 22:327–337.
   PubMed Web of Science ®Google Scholar
• Hamoudeh M, Diab R, Fessi H, Dumontet C, Cuchet D. (2008). Paclitaxel-loaded microparticles for intratumoral administration via the TMT technique: preparation, characterization, and preliminary antitumoral evaluation. Drug Dev Ind Pharm, 34:698–707.
   PubMed Web of Science ®Google Scholar
• Valizadeh H, Zakeri-Milani P, Barzegar-Jalali M, Mohammadi G, Danesh-Bahreini MA, Adibkia K et al. (2007). Preparation and characterization of solid dispersions of piroxicam with hydrophilic carriers. Drug Dev Ind Pharm, 33:45–56.
   PubMed Web of Science ®Google Scholar
• Aggarwal AK, Singh S. (2011). Physicochemical characterization and dissolution study of solid dispersions of diacereIn with polyethylene glycol 6000. Drug Dev Ind Pharm, 37:1181–1191.
   PubMed Web of Science ®Google Scholar
• Modi A, Tayade P. (2006). Enhancement of dissolution profile by solid dispersion (kneading) technique. AAPS PharmSciTech, 7:68.
   PubMed Web of Science ®Google Scholar
• Mura P, Manderioli A, Bramanti G, Ceccarelli L. (1996). Properties of Solid Dispersions of Naproxen In Various Polyethylene Glycols. Drug Dev Ind Pharm, 22:909–916.
   Web of Science ®Google Scholar
• Kabanov AV, Batrakova EV, Alakhov VY. (2002). Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release, 82:189–212.
   PubMed Web of Science ®Google Scholar
• Ahuja N, Katare OP, Singh B. (2007). Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers. Eur J Pharm Biopharm, 65:26–38.
   PubMed Web of Science ®Google Scholar
• Lei L, Liu X, Shen YY, Liu JY, Tang MF, Wang ZM et al. (2011). Zero-order release of 5-fluorouracil from PCL-based films featuring trilayered structures for stent application. Eur J Pharm Biopharm, 78:49–57.
   PubMed Web of Science ®Google Scholar
• Westedt U, Wittmar M, Hellwig M, Hanefeld P, Greiner A, Schaper AK et al. (2006). Paclitaxel releasing films consisting of poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) and their potential as biodegradable stent coatings. J Control Release, 111:235–246.
   PubMed Web of Science ®Google Scholar
• Huang CY, Chen CM, Lee YD. (2007). Synthesis of high loading and encapsulation efficient paclitaxel-loaded poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion. Int J Pharm, 338:267–275.
   PubMed Web of Science ®Google Scholar
• Costa P, Sousa Lobo JM. (2001). Modeling and comparison of dissolution profiles. Eur J Pharm Sci, 13:123–133.
   PubMed Web of Science ®Google Scholar
• Cheng L, Lei L, Guo S. (2010). In vitro and In vivo evaluation of praziquantel loaded implants based on PEG/PCL blends. Int J Pharm, 387:129–138.
   PubMed Web of Science ®Google Scholar
• Higuchi T. (1961). Rate of release of medicaments from ointment bases containing drugs In suspension. J Pharm Sci, 50:874–875.
   PubMed Web of Science ®Google Scholar
• Ritger PL, Peppas NA. (1987). A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release, 5:37–42.
   Google Scholar
• Paun IA, Moldovan A, Luculescu CR, Dinescu M. (2011). Biocompatible polymeric implants for controlled drug delivery produced by MAPLE. Appl Surf Sci, 257:10780–10788.
   Web of Science ®Google Scholar